{"nct_id":"NCT03432286","title":"A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2018-03-14","start_date_type":"ACTUAL","primary_completion_date":"2025-11","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}